Reliability And Validity Of Urdu Version Of Disabilities Of The Arm, Shoulder And Hand Questionnaire

May 6, 2024 updated by: Riphah International University

Reliability And Validity Of Urdu Version Of Disabilities Of The Arm, Shoulder And Hand Questionnaire Among Carpal Tunnel Syndrome Patients

The goal of study is to convert Disabilities Of The Arm, Shoulder And Hand Questionnaire into Urdu and test its reliability and validity among the Pakistani citizens. Also check its correlation with Boston carpal tunnel syndrome questionnaire and visual analogue scale as well.

Study Overview

Status

Completed

Detailed Description

A cross-sectional study will be conducted after approval from ethical review committee of Riphah international university of Faisalabad. Total of 90 participants will be included in this study from different community areas, hospitals and rehabilitation centers with carpal tunnel syndrome. 71 of them will be male and 19 will be female. Disabilities of the Arm, Shoulder, and Hand questionnaire will be correlated with Boston carpal tunnel syndrome questionnaire and visual analogue scales. These questionnaires will be filled by participants firstly for baseline, secondly after treatment and third one week later as a follow up. Written informed consents will be taken before filling questionnaires.

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Faisalabad, Punjab, Pakistan, 38000
        • Ripah International university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Carpal tunnel syndrome population of Pakistan will be included in study.

Description

Inclusion Criteria:

  • Age above 18 years.
  • Subjects with phalen's and Tinnel's test positive.

Exclusion Criteria:

Participants who had following conditions:

  • Diabetes mellitus, thyroid disease, rheumatoid arthritis, radiculopathy of cervical spine, cognitive impairment.
  • Hand surgery within previous 3 months.
  • Difficulty in understanding of language.
  • Musculoskeletal disorder.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disabilities Of The Arm, Shoulder And Hand Questionnaire
Time Frame: 1st day
Disabilities Of The Arm, Shoulder And Hand Questionnaire scale was designed to identify musculoskeletal disorders in the upper limbs, however it is also an appropriate outcome measure for Carpal Tunnel Syndrome. Disabilities Of The Arm, Shoulder And Hand Questionnaire questionnaire has 30 questions. These questions assess how difficult it is to execute a variety of functions due to arm, shoulder, or hand issues (21 items). They also look at intensity of symptoms (5 items), as well as psychological impact of condition (4 items).There are five response possibilities for each item, varying from little difficulty or no symptoms (1 point) to unable to do activity or severe condition (5 points).
1st day
Boston carpal tunnel syndrome questionnaire
Time Frame: 1st day
Boston carpal tunnel syndrome questionnaire is divided into two sub-scales: symptom severity & functional status. Every question has a 5-point scale, with 1 indicating no difficulties and 5 indicating significant symptoms or reduced function. Boston carpal tunnel syndrome questionnaire is a brief questionnaire that may be completed in 10 minutes.
1st day
Visual analogue scale
Time Frame: 1st day
Visual analogue scale is a tool which is used to measure pain severity. It ranges from 0-10 with 0 means no pain ranges between 1 to 3 mean mild pain, 4 to 6 represents moderate pain and 7 to 9 means severe pain whereas 10 means unbearable pain.
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Muhammad Kashif, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2021

Primary Completion (Actual)

December 15, 2023

Study Completion (Actual)

December 15, 2023

Study Registration Dates

First Submitted

June 6, 2022

First Submitted That Met QC Criteria

June 6, 2022

First Posted (Actual)

June 8, 2022

Study Record Updates

Last Update Posted (Actual)

May 7, 2024

Last Update Submitted That Met QC Criteria

May 6, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Subscribe